Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

TriSalus Life Sciences (TLSIW) Shares Issued (2022 - 2025)

TriSalus Life Sciences' Shares Issued history spans 4 years, with the latest figure at $87000.0 for Q4 2025.

  • For Q4 2025, Shares Issued rose 100.72% year-over-year to $87000.0; the TTM value through Dec 2025 reached $510000.0, up 17.78%, while the annual FY2025 figure was $510000.0, 17.78% up from the prior year.
  • Shares Issued reached $87000.0 in Q4 2025 per TLSIW's latest filing, up from -$21.8 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $22.2 million in Q2 2025 to a low of -$21.8 million in Q3 2025.
  • Average Shares Issued over 4 years is $101333.3, with a median of $90500.0 recorded in 2022.
  • Peak YoY movement for Shares Issued: plummeted 6889.39% in 2024, then skyrocketed 444120.0% in 2025.
  • A 4-year view of Shares Issued shows it stood at $94000.0 in 2022, then surged by 90.43% to $179000.0 in 2023, then tumbled by 6889.39% to -$12.2 million in 2024, then soared by 100.72% to $87000.0 in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Shares Issued are $87000.0 (Q4 2025), -$21.8 million (Q3 2025), and $22.2 million (Q2 2025).